drugset / Trial / NCT01679652

The Effects of Nebivolol on the NO-system in Patients With Essential Hypertension

NCT01679652

Phase 2 Completed 25 enrolled Erling Bjerregaard Pedersen
RandomizedCrossoverQuadruple-blindTreatment

Summary

Investigators want investigate the following hypothesis: 1. Nebivolol increases nitric oxide activity in the systemic circulation and the kidney 2. The increased activity of nitric oxide during nebivolol treatment can be demonstrated by inhibition of NO synthesis with L-NMMA. We expect increased responses in blood pressure and sodium excretion is expected during nebivolol treatment compared to placebo.

Timeline

Start
2012-08
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Nebivolol Other / unclassified 5 mg Oral